174 related articles for article (PubMed ID: 34363352)
1. Distinguishable Targeting of Non-Small Cell Lung Cancer Using Hyaluronan Functionalized Platinum Nanoclusters and Their Inhibition Behaviors of Proliferation, Invasion, Migration.
Liu T; Huang X; Zhao L; Xiao Z; Li Z; Xin Y; Yang S; Guo D; Zhao W; Mi Y; Li H
ChemistryOpen; 2021 Sep; 10(9):882-888. PubMed ID: 34363352
[TBL] [Abstract][Full Text] [Related]
2. Versatile Pt NCs-based chemotherapeutic agents significantly induce the apoptosis of cisplatin-resistant non-small cell lung cancer.
Xin Y; Huang X; Li Z; Zhao W; Wang C; Wang S; Yue X; Mo H; Li H
Biochem Biophys Res Commun; 2019 Apr; 512(2):218-223. PubMed ID: 30885437
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44.
Quan YH; Kim B; Park JH; Choi Y; Choi YH; Kim HK
Exp Lung Res; 2014 Dec; 40(10):475-84. PubMed ID: 25299431
[TBL] [Abstract][Full Text] [Related]
4. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
[TBL] [Abstract][Full Text] [Related]
5. Selective bio-labeling and induced apoptosis of hematopoietic cancer cells using dual-functional polyethylenimine-caged platinum nanoclusters.
Chen X; Zhou J; Yue X; Wang S; Yu B; Luo Y; Huang X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1465-1470. PubMed ID: 30029883
[TBL] [Abstract][Full Text] [Related]
6. The endocytic pathway of Pt nanoclusters and their induced apoptosis of A549 and A549/Cis cells through c-Myc/p53 and Bcl-2/caspase-3 signaling pathways.
Zhao L; Li H; Huang X; Liu T; Xin Y; Xiao Z; Zhao W; Miao S; Chen J; Li Z; Mi Y
Biomed Pharmacother; 2021 Dec; 144():112360. PubMed ID: 34794242
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
8. A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
Parashar P; Tripathi CB; Arya M; Kanoujia J; Singh M; Yadav A; Saraf SA
Drug Deliv Transl Res; 2019 Feb; 9(1):37-52. PubMed ID: 30178279
[TBL] [Abstract][Full Text] [Related]
9. Nano-Pt induced mitochondria-dependent apoptosis and cytoprotective autophagy in human NSCLC cells.
Wu J; Huang X; Xiao Z; Wang Q; Mu L; Yang S; Miao S; Chen J; Deng X; Deng C; Li H
Colloids Surf B Biointerfaces; 2023 Jul; 227():113344. PubMed ID: 37257302
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance.
Coleman KL; Chiaramonti M; Haddad B; Ranzenberger R; Henning H; Al Khashali H; Ray R; Darweesh B; Guthrie J; Heyl D; Evans HG
Cells; 2023 Jan; 12(3):. PubMed ID: 36766747
[TBL] [Abstract][Full Text] [Related]
11. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent Nanoclusters for Imaging of Cells/Stem Cells.
Molaabasi F; Hajipour-Verdom B; Alipour M; Naghib SM
Methods Mol Biol; 2020; 2125():27-37. PubMed ID: 31872332
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
[No Abstract] [Full Text] [Related]
14. Anti-tumor efficacy of hyaluronan-based nanoparticles for the co-delivery of drugs in lung cancer.
Jeannot V; Gauche C; Mazzaferro S; Couvet M; Vanwonterghem L; Henry M; Didier C; Vollaire J; Josserand V; Coll JL; Schatz C; Lecommandoux S; Hurbin A
J Control Release; 2018 Apr; 275():117-128. PubMed ID: 29474960
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
[TBL] [Abstract][Full Text] [Related]
16. CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells.
Yin J; Zhang H; Wu X; Zhang Y; Li J; Shen J; Zhao Y; Xiao Z; Lu L; Huang C; Zhang Z; Du F; Wu Y; Kaboli PJ; Cho CH; Yuan D; Li M
Int J Mol Med; 2020 Jun; 45(6):1783-1792. PubMed ID: 32236608
[TBL] [Abstract][Full Text] [Related]
17. Novel Platinum Nanoclusters Activate PI3K/AKT/mTOR Signaling Pathway-Mediated Autophagy for Cisplatin-Resistant Ovarian Cancer Therapy.
Zhang M; Yue H; Huang X; Wang J; Li Z; Deng X
ACS Appl Mater Interfaces; 2022 Nov; 14(43):48502-48514. PubMed ID: 36261925
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
Zou J; Su S; Chen Z; Liang F; Zeng Y; Cen W; Zhang X; Xia Y; Huang D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3456-3464. PubMed ID: 31469318
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic Acid Grafted Nanoparticles of a Platinum(II)-Silicon(IV) Phthalocyanine Conjugate for Tumor and Mitochondria-Targeted Photodynamic Therapy in Red Light.
Mitra K; Samso M; Lyons CE; Hartman MCT
J Mater Chem B; 2018 Dec; 6(45):7373-7377. PubMed ID: 31372221
[TBL] [Abstract][Full Text] [Related]
20. Effect of Nano-Platinum on Proliferation and Apoptosis of Non-Small Cell Lung Cancer Cells via P53 Pathway.
Liu Y; Hu F; Zhao L
J Nanosci Nanotechnol; 2021 Feb; 21(2):903-908. PubMed ID: 33183422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
